Ultragenyx Pharmaceutical Inc. (RARE) Dividend History
Income profile from 2011 to 2025 with payout safety and yield-on-cost trend
RARE Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
1 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
RARE Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
RARE Dividend History
No dividend payment history available
Get RARE's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Ultragenyx Pharmaceutical Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
RARE has raised its dividend for 1 consecutive year.
Total Shareholder Returns
Beyond cash dividends, RARE returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -71.1%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $5,035 today.
RARE Annual Dividend History (2011–2025)
15 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-5.83 | — | — | — |
| 2024 | $0.00 | — | 0 | $-6.29 | — | — | — |
| 2023 | $0.00 | — | 0 | $-8.25 | — | — | — |
| 2022 | $0.00 | — | 0 | $-10.12 | — | — | — |
| 2021 | $0.00 | — | 0 | $-6.70 | — | — | — |
| 2020 | $0.00 | — | 0 | $-3.07 | — | — | — |
| 2019 | $0.00 | — | 0 | $-7.12 | — | — | — |
| 2018 | $0.00 | — | 0 | $-3.97 | — | — | — |
| 2017 | $0.00 | — | 0 | $-7.12 | — | — | — |
| 2016 | $0.00 | — | 0 | $-6.21 | — | — | — |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RARE — Frequently Asked Questions
Quick answers to the most common questions about buying RARE stock.
How much dividend does RARE pay per share?
Ultragenyx Pharmaceutical Inc. (RARE) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is RARE's next ex-dividend date?
RARE's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. RARE typically pays dividends quarterly.
Is RARE's dividend safe?
RARE's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The 1-year growth streak provides moderate confidence.
How many years has RARE increased its dividend?
RARE has 1 consecutive years of dividend growth. The 5-year dividend CAGR is N/A.
How often does RARE pay dividends?
Ultragenyx Pharmaceutical Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 14+ years from 2011 to 2025.
How much would $10,000 invested in RARE grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in RARE five years ago would be worth approximately $2,891 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is RARE's yield on cost for long-term holders?
RARE's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.